Dr. Lara Savas, PhD
Claim this profileMore about Lara Savas, PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Lara Savas, PhD has experience with
- Salud En Mis Manos - Dissemination And Implementation Assistance
- Salud En Mis Manos- Usual Implementation Practice
Breakdown of trials Lara Savas, PhD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lara Savas, PhD specialize in?
Lara Savas, PhD focuses on Breast Cancer and Cervical Cancer. In particular, much of their work with Breast Cancer has involved treating patients, or patients who are undergoing treatment.
Is Lara Savas, PhD currently recruiting for clinical trials?
No, Lara Savas, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lara Savas, PhD has studied deeply?
Yes, Lara Savas, PhD has studied treatments such as Salud en Mis Manos - Dissemination and Implementation Assistance, Salud en Mis Manos- Usual Implementation Practice.
What is the best way to schedule an appointment with Lara Savas, PhD?
Apply for one of the trials that Lara Savas, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.